Saturday, November 30th, 2024

Elite UK REIT Expands into PBSA: A Recession-Resistant Yield Play with 10%+ Dividend Yield






In-Depth Analysis of Elite UK REIT and Trading Insights



In-Depth Analysis of Elite UK REIT and Trading Insights

Authored by UOB Kay Hian, Dated: 28 November 2024

Elite UK REIT: A Strategic Expansion and Growth Trajectory

Elite UK REIT, a UK-focused S-REIT listed on the SGX, is making strategic expansions that position it as a formidable player in the real estate sector. With its focus on social infrastructure and living assets, the company is redefining its investment strategy. The REIT has broadened its mandate to include Purpose-Built Student Accommodation (PBSA) and rental housing, aiming to redevelop sites like Lindsay House in Dundee, Scotland, and Newport Road in Cardiff, Wales, into PBSA.

Investment Strategy Expansion

Elite’s expansion into PBSA is supported by its sponsor, Sunway RE Capital, which owns five PBSA assets across major UK cities, forming a robust acquisition pipeline. This move positions Elite as a recession-resistant, counter-cyclical yield play, effectively insulating it from economic downturns. The REIT maintains a BUY recommendation with a target price of £0.38, underscoring its potential for significant growth.

Employment Services and Fraud Prevention

The British government’s transformation of jobcentres into comprehensive career service hubs is another strategic advantage for Elite. This initiative includes hiring 3,400 “benefits police” to enhance fraud prevention, along with expanding mental health support services. These developments promise stable cash flows and enhance the REIT’s appeal as a safe investment.

Financial Health and Projections

Elite’s financials indicate strong performance with a consistent net turnover of £38 million projected from 2024 to 2026. The company anticipates net profits of £17 million by 2025, supported by strategic divestments and a robust balance sheet. With a compelling dividend yield and a solid net profit margin, Elite UK REIT remains a lucrative investment opportunity.

Jiutian Chemical Group: A Promising Trading Buy

Jiutian Chemical Group is currently positioned as a trading buy, with its stock price showing resilience above a key resistance-turned-support zone. The rising RSI hints at potential upside, making it an attractive prospect for investors. The stock is expected to test a target price of S\$0.037, with stops suggested at S\$0.026. Investors are advised to initiate trades if the stock hits the entry price range within three trading days, with an estimated timeframe of 1-2 weeks for this trading idea.

SATS: Evaluating the Trading Sell Recommendation

SATS, a prominent player in the aviation services sector, is currently under a trading sell recommendation. The stock is showing signs of forming a price top at S\$4.06, with the middle Bollinger band acting as a cap. The RSI is below its neutral level, suggesting potential for the stock price to move lower. A target price of S\$3.59 is set, with a protective stop at S\$3.92. Investors are encouraged to consider this trading idea if the stock reaches the entry price range within three trading days, with a projected timeframe of 1-2 weeks.

Despite the trading sell recommendation, SATS holds a fundamental BUY rating from institutional research, with a long-term target price of S\$4.30, indicating potential for recovery and growth.

For further insights and detailed analysis, please refer to the original report by UOB Kay Hian, dated 28 November 2024.


HM Sampoerna: Resilience Amidst Challenges in Indonesia’s Tobacco Industry

Date: October 30, 2024Broker: PT Maybank Sekuritas Indonesia Stock Recommendation and Price Target Recommendation: Maintain BUY 12-Month Price Target (TP): IDR 850 (revised down from IDR 1,050), which implies a potential 30% upside from...

TMBThanachart Bank (TTB TB): Strategic Upgrades and Positive Outlook Amidst Challenging Market Conditions

Date of Report 21 October 2024 Broker Name UOB Kay Hian Company Overview TMBThanachart Bank (TTB TB) is the sixth largest bank in Thailand, holding approximately 10% of the country’s credit market. The bank...

CSPC Pharmaceutical’s 9M24 Results Disappoint; Targets Growth in 2025 Despite Challenges

Regional Morning Notes: A Deep Dive into CSPC Pharmaceutical Group Regional Morning Notes: A Deep Dive into CSPC Pharmaceutical Group Date: November 18, 2024 Broker: UOB Kay Hian Introduction In a comprehensive analysis by...